DAVID B MACLEAN, MD
Osteopathic Medicine at Hoppin St, Providence, RI
License number
Rhode Island MD07172
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
1 Hoppin St SUITE 200, Providence, RI 02903
Phone
(401) 444-8344
(401) 444-7870 (Fax)
(401) 444-7870 (Fax)
Personal information
See more information about DAVID B MACLEAN at radaris.comName
Address
Phone
41 Laurel Ave, Providence, RI 02906
9 Stimpson St, Middletown, RI 02842
Organization information
See more information about DAVID B MACLEAN at bizstanding.comDavid B Maclean MD
593 Eddy St, Providence, RI 02903
Industry:
Medical Doctor's Office
Medical Doctors:
Andrew Maslow (Medical Doctor),David Washington (Medical Doctor),Robert Klein (Medical Doctor),...
Professional information
David B Maclean, Providence RI
Specialties:
Endocrinologist
Address:
1 Hoppin St, Providence, RI 02903
Education:
University of Calgary, Faculty of Medicine - Doctor of Medicine*
Tufts Medical Center - Fellowship - Endocrinology*
Queen Elizabeth II Health Sciences Centre - Victoria Building - Residency - Internal Medicine*
Jewish General Hospital - Residency - Family Medicine*
Tufts Medical Center - Fellowship - Endocrinology*
Queen Elizabeth II Health Sciences Centre - Victoria Building - Residency - Internal Medicine*
Jewish General Hospital - Residency - Family Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine)*
Physician At Self
Position:
physician at self
Location:
Providence, Rhode Island Area
Industry:
Health, Wellness and Fitness
Work:
self
-
physician
Education:
Harvard University
Use Of Estrogen Antagonists And Estrogen Agonists In Inhibiting Pathological Conditions
US Patent:
6613796, Sep 2, 2003
Filed:
Nov 15, 2001
Appl. No.:
09/999291
Inventors:
David B. Maclean - Providence RI
David D. Thompson - Gales Ferry CT
David D. Thompson - Gales Ferry CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 3140
US Classification:
514428, 514315, 514319, 514343, 514429
Abstract:
The present invention provides novel methods of inhibiting pathological conditions related to organ systems which respond to estrogen agonists comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I.
Use Of Estrogen Antagonists And Estrogen Agonists In Inhibiting Pathological Conditions
US Patent:
6403611, Jun 11, 2002
Filed:
Mar 9, 2001
Appl. No.:
09/803516
Inventors:
David B. Maclean - Providence RI
David D. Thompson - Gales Ferry CT
David D. Thompson - Gales Ferry CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31445
US Classification:
514315, 514428, 514429
Abstract:
The present invention provides novel methods of inhibiting pathological conditions related to organ systems which respond to estrogen agonists comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I.
Combination Therapy To Treat Osteoporosis - Polyphosphonates And Estrogen Agonists
US Patent:
5773477, Jun 30, 1998
Filed:
Feb 21, 1997
Appl. No.:
8/803707
Inventors:
David B. MacLean - Providence RI
David D. Thompson - Gales Ferry CT
David D. Thompson - Gales Ferry CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31135, A61K 3166
US Classification:
514648
Abstract:
The present invention provides novel methods of treating or preventing osteoporosis comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1## wherein R. sup. 1 and R. sup. 2 may be the same or different provided that, when R. sup. 1 and R. sup. 2 are the same, each is a methyl or ethyl group, and, when R. sup. 1 and R. sup. 2 are different, one of them is a methyl or ethyl group and the other is hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof; together with a bone resorption inhibiting polyphosphonate.
Combination Therapy To Treat Osteoporosis-Polyphosphonates And Estrogen Agonists
US Patent:
6100301, Aug 8, 2000
Filed:
Jun 5, 1998
Appl. No.:
9/092100
Inventors:
David B. Maclean - Providence RI
David D. Thompson - Gales Ferry CT
David D. Thompson - Gales Ferry CT
Assignee:
Pfizer Inc - New York NY
International Classification:
A61K 31135, A61K 3800
US Classification:
514648
Abstract:
The present invention provides novel methods of treating or preventing osteoporosis comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1## wherein R. sup. 1 and R. sup. 2 may be the same or different provided that, when R. sup. 1 and R. sup. 2 are the same, each is a methyl or ethyl group, and, when R. sup. 1 and R. sup. 2 are different, one of them is a methyl or ethyl group and the other is hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof; together with a bone resorption inhibiting polyphosphonate, or with parathyroid hormone.
Inhibition Of Autoimmune Diseases
US Patent:
5985932, Nov 16, 1999
Filed:
Feb 21, 1997
Appl. No.:
8/804346
Inventors:
David B. MacLean - Providence RI
David D. Thompson - Gales Ferry CT
David D. Thompson - Gales Ferry CT
Assignee:
Pfizer Inc - New York NY
International Classification:
A61K 31135
US Classification:
514648
Abstract:
The present invention provides novel methods of inhibition of autoimmune diseases comprising administering to a mammal in need of treatment an effective amount of a compound of formula I ##STR1## wherein R. sup. 1 and R. sup. 2 may be the same or different provided that, when R. sup. 1 and R. sup. 2 are the same, each is a methyl or ethyl group, and, when R. sup. 1 and R. sup. 2 are different, one of them is a methyl or ethyl group and the other is hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof.
Combination Therapy To Prevent Bone Loss Parathyroid Hormone And Estrogen Agonists
US Patent:
5861438, Jan 19, 1999
Filed:
Feb 21, 1997
Appl. No.:
8/803712
Inventors:
David B. MacLean - Providence RI
David D. Thompson - Gales Ferry CT
David D. Thompson - Gales Ferry CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 3800, A61K 31135
US Classification:
514648
Abstract:
The present invention provides novel methods of inhibiting bone loss comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1## wherein R. sup. 1 and R. sup. 2 may be the same or different provided that, when R. sup. 1 and R. sup. 2 are the same, each is a methyl or ethyl group, and, when R. sup. 1 and R. sup. 2 are different, one of them is a methyl or ethyl group and the other is a hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof; together with or in combination with parathyroid hormone.
Therapy For Andropause Using Estrogen Agonists/Antagonists And Testosterone
US Patent:
2005028, Dec 29, 2005
Filed:
Sep 2, 2005
Appl. No.:
11/219267
Inventors:
David MacLean - Providence RI, US
International Classification:
A61K031/4709
US Classification:
514307000
Abstract:
The present invention concerns the treatment of andropause and related conditions using a combination of an estrogen agonist/antagonist and testosterone.
Use Of Estrogen Antagonists And Estrogen Agonists In Inhibiting Pathological Conditions
US Patent:
6274618, Aug 14, 2001
Filed:
May 19, 1999
Appl. No.:
9/314758
Inventors:
David B. MacLean - Providence RI
David D. Thompson - Gales Ferry CT
David D. Thompson - Gales Ferry CT
Assignee:
Pfizer Inc - New York NY
International Classification:
A61K 3140, A01N 4336
US Classification:
514428
Abstract:
The present invention provides novel methods of inhibiting pathological conditions related to organ systems which respond to estrogen agonists comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1##.